Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin81.3%+1.1pp80.2%-0.6pp80.8%-1.3pp82.1%+2.4pp79.8%-0.8pp
Operating margin25.8%+4.7pp21.1%+1.9pp19.2%+0.6pp18.7%+16.2pp2.5%-0.7pp
Net margin19.4%+2.6pp16.9%+6.0pp10.8%+1.6pp9.2%+9.8pp-0.6%-1.2pp
EBITDA margin26.5%+4.6pp21.9%+1.6pp20.3%+0.5pp19.8%+16.2pp3.7%-0.9pp
Efficiency
Inventory turnover37.2×-3.8×41×-23.9×64.9×+48.1×16.8×+4.6×12.2×+8.8×
Liquidity
Current ratio0.9×+0.1×0.7×-0.2×
Quick ratio0.9×+0.1×0.7×-0.2×
Cash ratio0.2×0.0×0.2×-0.2×0.5×
Leverage
Debt-to-assets0.4×+0.1×0.3×0.0×0.3×
Net debt / EBITDA+0.4×0.6×+0.9×-0.4×
Interest coverage8.3×+2.5×5.8×+1.5×4.4×+0.1×4.3×+3.6×0.6×-0.3×
Per Share
Book value per share-$1.12-45.8%-$0.77+52.3%-$1.60+21.3%-$2.04+10.5%-$2.28+10.0%
Valuation
Market capitalization$3.72B-17.2%$4.49B+49.1%$3.01B+73.2%$1.74B+46.2%$1.19B-23.5%
Enterprise value$4.05B-12.7%$4.64B+59.0%$2.92B
Price / earnings14.8×
Price / sales2.9×-0.7×3.6×+1.1×2.5×+1.1×1.5×+0.5×-0.3×
EV / EBITDA11.8×-5.2×17.1×+4.9×12.2×
EV / sales3.1×-0.6×3.7×+1.3×2.5×
Earnings yield6.8%+2.1pp4.7%+0.4pp4.3%-2.0pp6.2%+6.8pp-0.6%-1.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Indivior Pharmaceuticals, Inc. 's profit margins?
Indivior Pharmaceuticals, Inc. (INDV) runs a 81.3% gross margin and a 25.8% operating margin, with a 19.4% net margin.
Where do Indivior Pharmaceuticals, Inc. 's ratios come from?
Every ratio is computed from Indivior Pharmaceuticals, Inc. 's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.